Dan D’Agostino

Dan is a highly-experienced investment banking with a passion for biotechnology, medical technology and biopharmaceuticals.

Mr. D’Agostino brings a 20+ year history of leadership in investment banking, mergers & acquisitions banking with a specific passion for human healthcare, medical technology, biopharma and biotech. He is currently Managing Director and Head of Healthcare at RW Pressprich & Co., a 100-person full-service investment bank focused on growth companies in Healthcare, Aviation and Energy. Prior to this, he held positions of Managing Partner, CEO, CBO and CFO at several investment banking firms including AmeriTech Advisors, ThinkEquity, Punk, Ziegel & Company. His mergers & acquisition experience includes Deutsche Bank/ BT Alex.Brown and Wasserstein, Perella & Co. In addition, Dan has worked with companies in the biotech, medtech, specialty pharma and energy/cleantech sectors. His experience includes leading buyside and sellside M&A advisory assignments, IPO’s, public debt and equity financings, senior debt facilities and private placements.

He earned an MBA in Finance and Master’s Degree in International Affairs from Columbia University, and a Bachelor of Science in Accounting from Tulane University. He attended the Program in Biotechnology for executives, School of Engineering and Applied Science at the University of Pennsylvania. He has Series 24, 79, 7, 63 and 28 certifications.